288 related articles for article (PubMed ID: 17868650)
41. T-cell receptor (TCR)/CD3 is involved in sulfated polymannuroguluronate (SPMG)-induced T lymphocyte activation.
Miao B; Li J; Fu X; Ding J; Geng M
Int Immunopharmacol; 2005 Jul; 5(7-8):1171-82. PubMed ID: 15914322
[TBL] [Abstract][Full Text] [Related]
42. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.
Cassoni P; Sapino A; Deaglio S; Bussolati B; Volante M; Munaron L; Albini A; Torrisi A; Bussolati G
Cancer Res; 2002 Apr; 62(8):2406-13. PubMed ID: 11956104
[TBL] [Abstract][Full Text] [Related]
43. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes.
Miao B; Geng M; Li J; Li F; Chen H; Guan H; Ding J
Biochem Pharmacol; 2004 Aug; 68(4):641-9. PubMed ID: 15276071
[TBL] [Abstract][Full Text] [Related]
44. Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure.
Olsen MW; Ley CD; Junker N; Hansen AJ; Lund EL; Kristjansen PE
Neoplasia; 2006 May; 8(5):364-72. PubMed ID: 16790085
[TBL] [Abstract][Full Text] [Related]
45. Basic fibroblast growth factor as a growth factor for SRV-2-infected simian retroperitoneal fibromatosis cells, an animal model for AIDS related Kaposi's sarcoma.
Chung CH; Chiang J; Jiang CM; Chen YY; Huang CY; Chen PG; Chen YJ
Neoplasma; 2001; 48(3):192-9. PubMed ID: 11583288
[TBL] [Abstract][Full Text] [Related]
46. Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.
Shailubhai K; Dheer S; Picker D; Kaur G; Sausville EA; Jacob GS
J Exp Ther Oncol; 2004 Dec; 4(4):267-79. PubMed ID: 15844657
[TBL] [Abstract][Full Text] [Related]
47. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
48. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
49. Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis.
Moon EJ; Lee YM; Kim KW
Oncol Rep; 2003; 10(3):617-21. PubMed ID: 12684633
[TBL] [Abstract][Full Text] [Related]
50. Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.
Wu Z; Cavallaro U; Marchisio PC; Soria MR; Maier JA
Am J Pathol; 1998 Jun; 152(6):1599-605. PubMed ID: 9626063
[TBL] [Abstract][Full Text] [Related]
51. HIV-tat protein is a heparin-binding angiogenic growth factor.
Albini A; Benelli R; Presta M; Rusnati M; Ziche M; Rubartelli A; Paglialunga G; Bussolino F; Noonan D
Oncogene; 1996 Jan; 12(2):289-97. PubMed ID: 8570206
[TBL] [Abstract][Full Text] [Related]
52. [Effect of sulfated polymannuroguluronate on Tat induced proinflammatory cytokines release in THP-1 cells and its mechanism of action].
Hui B; Geng MY; Li J
Yao Xue Xue Bao; 2006 Apr; 41(4):338-41. PubMed ID: 16856479
[TBL] [Abstract][Full Text] [Related]
53. Nucleosomes bind fibroblast growth factor-2 for increased angiogenesis in vitro and in vivo.
Tanner JE; Forté A; Panchal C
Mol Cancer Res; 2004 May; 2(5):281-8. PubMed ID: 15192121
[TBL] [Abstract][Full Text] [Related]
54. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone.
Lunardi-Iskandar Y; Bryant JL; Zeman RA; Lam VH; Samaniego F; Besnier JM; Hermans P; Thierry AR; Gill P; Gallo RC
Nature; 1995 May; 375(6526):64-8. PubMed ID: 7723844
[TBL] [Abstract][Full Text] [Related]
55. Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis.
Mallery SR; Bailer RT; Hohl CM; Ng-Bautista CL; Ness GM; Livingston BE; Hout BL; Stephens RE; Brierley GP
J Cell Biochem; 1995 Nov; 59(3):317-28. PubMed ID: 8567750
[TBL] [Abstract][Full Text] [Related]
56. Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
Urbinati C; Bugatti A; Oreste P; Zoppetti G; Waltenberger J; Mitola S; Ribatti D; Presta M; Rusnati M
FEBS Lett; 2004 Jun; 568(1-3):171-7. PubMed ID: 15196942
[TBL] [Abstract][Full Text] [Related]
57. Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
Yi EY; Jeong EJ; Song HS; Lee MS; Kang DW; Joo JH; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Kim YJ
Int J Oncol; 2004 Aug; 25(2):365-72. PubMed ID: 15254733
[TBL] [Abstract][Full Text] [Related]
58. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
[TBL] [Abstract][Full Text] [Related]
59. Identification of a clonal form of HIV in early Kaposi's sarcoma: evidence for a novel model of oncogenesis, "sequential neoplasia".
McGrath MS; Shiramizu BT; Herndier BG
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):379-85. PubMed ID: 7882103
[TBL] [Abstract][Full Text] [Related]
60. Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma.
Ensoli B; Stürzl M; Monini P
Semin Cancer Biol; 2000 Oct; 10(5):367-81. PubMed ID: 11100885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
